OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials
Isobel P. Taylor, J. Alejandro López
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8117-8129
Open Access | Times Cited: 8
Isobel P. Taylor, J. Alejandro López
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8117-8129
Open Access | Times Cited: 8
Showing 8 citing articles:
Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer
Aseem Rai Bhatnagar, Farzan Siddiqui, Gazala Khan, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1065-1065
Open Access | Times Cited: 4
Aseem Rai Bhatnagar, Farzan Siddiqui, Gazala Khan, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1065-1065
Open Access | Times Cited: 4
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demir, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Tarık Demir, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 10
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 10
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
(2024)
Open Access | Times Cited: 2
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
(2024)
Open Access | Times Cited: 2
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9912-9912
Open Access | Times Cited: 2
Shivani Thoidingjam, Aseem Rai Bhatnagar, Sushmitha Sriramulu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9912-9912
Open Access | Times Cited: 2
Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer
Shiyu Liu, Fan Li, Li Deng, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 275-285
Open Access | Times Cited: 5
Shiyu Liu, Fan Li, Li Deng, et al.
Molecular Therapy — Oncolytics (2023) Vol. 30, pp. 275-285
Open Access | Times Cited: 5
Triple-regulated conditionally replicating adenovirus for effective and safer treatment of peritoneal carcinomatosis
Junichi Kamizono, Yuya Nishikawaji, Satoshi Nagano, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 737, pp. 150894-150894
Closed Access
Junichi Kamizono, Yuya Nishikawaji, Satoshi Nagano, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 737, pp. 150894-150894
Closed Access
Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer
Karie Runcie, Yadriel Bracero, Avishai Samouha, et al.
The Oncologist (2024)
Open Access
Karie Runcie, Yadriel Bracero, Avishai Samouha, et al.
The Oncologist (2024)
Open Access
